Novozymes closes majority stake acquisition of Synergia

Danish firm Novozymes, which is specialized in enzymes, has closed the transaction of the majority stake in Synergia Life Sciences, which is based in India.

Photo: Novozymes/PR

Danish enzymes company Novozymes has completed the purchase of the majority stake in Indian biotech firm Synergia Life Sciences, it reports in a press release on Friday.

The acquisition involved 60 percent of outstanding shares in Synergia Life Sciences and was announced on Nov. 30.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs